EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples

Marianna Graziosi iD, Julia Sarah Rohde iD, Stephanie Lake, Philippe Lucas, Scott Barry Kaufman, David Bryce Yaden

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0314469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Marianna Graziosi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD,…. Hauptthemen laut MEDLINE: Hallucinogens, Psychometrics, Emotions. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to develop and validate a short-form version of the AWE-S (AWE-SF) within psychedelic samples, to reduce participant burden while maintaining psychometric integrity. Across five studies, we first replicated the original six-factor structure of the AWE-S through exploratory and confirmatory factor analyses (Study 1), leading to the creation of the 12-item AWE-SF (Study 2–3). We then established the AWE-SF’s initial and predictive validity by correlating it with relevant emotional, psychedelic, and well-being outcomes (Study 4–6). The AWE-SF demonstrated strong positive associations with positive emotions and was also linked to openness to experience. Moreover, the AWE-SF effectively predicted both mystical-type and challenging psychedelic experiences, as well as long-term well-being outcomes such as life satisfaction and psychological richness. In particular, the facets of connection and vastness were associated with positive emotional states and mystical-type experience, while accommodation and self-loss were associated with negative emotional states and challenging psychedelic experience. These findings suggest that the AWE-SF is a robust, reliable, and accessible tool for measuring awe experience.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensPsychometricsEmotionsHumansMaleFemaleAdultYoung AdultSurveys and QuestionnairesPersonal SatisfactionMiddle AgedAdolescentFactor Analysis, Statistical

Substanzen

Hallucinogens

Autor:innen und Institutionen

  • Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States of America.
  • Department of Clinical Psychology, Hofstra University, Hempstead, NY, United States of America.
  • Department of Clinical Psychology, Virginia Tech University, Blacksburg, VA, United States of America.
  • UCLA Center for Cannabis and Cannabinoids, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, United States of America.
  • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
  • Michigan Psychedelic Center, University of Michigan, Ann Arbor, MI, United States of America.

ORCID-Profile: Marianna Graziosi, Julia Sarah Rohde

Zitieren

APA

Graziosi, M., Rohde, J. S., Lake, S., Lucas, P., Kaufman, S. B., & Yaden, D. B. (2024). Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples. PLOS ONE. https://doi.org/10.1371/journal.pone.0314469

Vancouver

Graziosi M, Rohde JS, Lake S, Lucas P, Kaufman SB, Yaden DB. Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples. PLOS ONE. 2024. doi:10.1371/journal.pone.0314469

BibTeX
@article{Graziosi2024,
  author = {Graziosi, Marianna and Rohde, Julia Sarah and Lake, Stephanie and Lucas, Philippe and Kaufman, Scott Barry and Yaden, David Bryce},
  title = {Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0314469}
}
Kostenlos starten →